Hemex Health, Inc.
Hemex Health is dedicated to breaking traditional barriers in healthcare diagnostics by designing innovative, affordable, portable, and easy-to-use diagnostic devices. Their mission is to expand the potential of diagnostics for important conditions, making accurate tests accessible to new locations and populations, especially in remote and challenging settings. They collaborate with academic institutions and industry partners to develop technologies like the Gazelle diagnostic system, which is used for screening diseases such as sickle cell disease, beta thalassemia, and ferritin deficiency. Hemex Health's products aim to empower healthcare providers worldwide, improve early diagnosis, and reduce child mortality related to hemoglobin disorders.
Industries
Nr. of Employees
small (1-50)
Hemex Health, Inc.
Patents
Combination of reflective and transmissive sensors with characteristic wavelengths for physiological monitoring
US-12616399-B2
View DetailsUsing electrophoresis for disease detection based on controlled molecular charge
US-11971384-B2
View Details
Combination of reflective and transmissive sensors with characteristic wavelengths for physiological monitoring
US-12616399-B2
View DetailsUsing electrophoresis for disease detection based on controlled molecular charge
US-11971384-B2
View DetailsProducts
Portable point-of-care diagnostic reader (hemoglobin variant testing)
A portable reader that runs a miniaturized electrophoresis assay to identify and quantify hemoglobin variants, designed for rapid results in decentralized settings.
Cloud-based report management application
Web-accessible cloud application for storage, viewing, printing, and sharing of diagnostic reports; includes dashboard and API modules for integration.
Point-of-care ferritin test (in development)
A point-of-care ferritin test designed to measure ferritin from whole blood, serum, or plasma for decentralized iron status assessment; availability planned in select markets.
Portable point-of-care diagnostic reader (hemoglobin variant testing)
A portable reader that runs a miniaturized electrophoresis assay to identify and quantify hemoglobin variants, designed for rapid results in decentralized settings.
Cloud-based report management application
Web-accessible cloud application for storage, viewing, printing, and sharing of diagnostic reports; includes dashboard and API modules for integration.
Point-of-care ferritin test (in development)
A point-of-care ferritin test designed to measure ferritin from whole blood, serum, or plasma for decentralized iron status assessment; availability planned in select markets.
Services
Provision of a cloud application for storing, viewing, printing, and exporting patient reports and APIs for integration with third-party EMR systems.
On-site training and operational support for deployment of point-of-care diagnostic readers in community screening events and healthcare facilities.
Country-specific distribution via local resellers and regional service centers for sales, product availability, and technical support.
Provision of a cloud application for storing, viewing, printing, and exporting patient reports and APIs for integration with third-party EMR systems.
On-site training and operational support for deployment of point-of-care diagnostic readers in community screening events and healthcare facilities.
Country-specific distribution via local resellers and regional service centers for sales, product availability, and technical support.
Expertise Areas
- Point-of-care diagnostics for low-resource settings
- Hemoglobinopathy testing and screening programs
- Cloud-based clinical data management and EMR integration
- Assay development for decentralized testing (including ferritin)
Key Technologies
- Microchip electrophoresis
- Miniaturized electrophoresis hemoglobin analysis
- Point-of-care immunoassay (ferritin) compatible with whole blood/serum/plasma
- Embedded portable diagnostic hardware
News & Updates
2023 Gazelle launched in Vietnam
Hemex partnered with Biomedical Vietnam to collaborate with Nghia Lo Regional General Hospital for beta thalassemia screening in the Northern Highland region.
2023 Ramjas College Screening Camp
On World Thalassemia Day, education and screening for beta thalassemia were provided to students at Delhi University College, with counseling on the condition.
2023 Tamil Nadu Screening Event
Gazelle was used for screening at the DPH Health camp in Ooty Medical College and showcased to the Chief Minister of Tamil Nadu and the Mission Director of National Health Mission.
2023 Beta Thalassemia Launch at Gangaram Hospital
On World Thalassemia Day, the Gazelle beta thalassemia test was officially launched at Sir Ganga Ram Hospital, New Delhi, with on-the-spot screening.
2023 ZAMBIA WORLD SICKLE CELL DAY EVENT
Reach a Child Initiative Zambia used Gazelle to screen 8,000 children in the Greater Lusaka Region.
2023 TRAINING AT HOLY CROSS ORTHODOX MISSION HOSPITAL OF UGANDA
Doctors in Uganda received training on Gazelle to improve healthcare for children with sickle cell disease.
2023 Gazelle launched in Vietnam
Hemex partnered with Biomedical Vietnam to collaborate with Nghia Lo Regional General Hospital for beta thalassemia screening in the Northern Highland region.
2023 Ramjas College Screening Camp
On World Thalassemia Day, education and screening for beta thalassemia were provided to students at Delhi University College, with counseling on the condition.
2023 Tamil Nadu Screening Event
Gazelle was used for screening at the DPH Health camp in Ooty Medical College and showcased to the Chief Minister of Tamil Nadu and the Mission Director of National Health Mission.
2023 Beta Thalassemia Launch at Gangaram Hospital
On World Thalassemia Day, the Gazelle beta thalassemia test was officially launched at Sir Ganga Ram Hospital, New Delhi, with on-the-spot screening.
2023 ZAMBIA WORLD SICKLE CELL DAY EVENT
Reach a Child Initiative Zambia used Gazelle to screen 8,000 children in the Greater Lusaka Region.
2023 TRAINING AT HOLY CROSS ORTHODOX MISSION HOSPITAL OF UGANDA
Doctors in Uganda received training on Gazelle to improve healthcare for children with sickle cell disease.